id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-295144-tyyc81uc	Stradner, Martin H.	Rheumatic Musculoskeletal Diseases and COVID-19 A Review of the First 6 Months of the Pandemic	2020-10-09		.txt	text/plain	9901	442	39	In this review, we summarize the published cases of COVID-19 infections in RMD patients, including patients with inflammatory arthritis and connective tissue diseases as well as anti-phospholipid syndrome and Kawasaki syndrome. It also reviews the general risk of viral infections in patients with RMD, the impact of disease modifying anti-rheumatic drugs (DMARDs) on the outcome of infections, and gives a comparison between present and previous coronavirus pandemics. This argues against a protective role of HCQ (in the usually administered dose for RMD patients) in SARS-CoV-2 infection, which is also supported by pharmacological in vitro data describing a much higher level needed for effective viral inhibition (61) . In conclusion, data published in the first 6 months do not consistently describe a higher risk for infection with SARS-CoV-2 or a more severe course of COVID-19 in patients with either inflammatory arthritis or connective tissue diseases.	./cache/cord-295144-tyyc81uc.txt	./txt/cord-295144-tyyc81uc.txt